Rohit Jain, PhD. (@rohitjain_18) 's Twitter Profile
Rohit Jain, PhD.

@rohitjain_18

Immunologist and cancer researcher 🇦🇹 🇪🇺 🇦🇺 🇮🇳 Opinions are my own.

ID: 831032535098331136

calendar_today13-02-2017 06:49:31

151 Tweet

194 Followers

195 Following

Rohit Jain, PhD. (@rohitjain_18) 's Twitter Profile Photo

Another impressive study from the @Lammermann_Lab MPI of Immunobiology & Epigenetics highlighting the role of integrins and Kit ligand in the niche-based organisation of mast cells within the skin. Must read!

WeichhartLab (@weichhartlab) 's Twitter Profile Photo

We are recruiting!! Are you interested in #Immunometabolism, #Macrophages, and their production of novel metabolites during health & disease? We have an open position for a postdoc in Vienna at MedUni Wien. Please DM or email me!

We are recruiting!! 
Are you interested in #Immunometabolism, #Macrophages, and their production of novel metabolites during health &amp; disease? We have an open position for a postdoc in Vienna at <a href="/MedUni_Wien/">MedUni Wien</a>. Please DM or email me!
MedUni Wien (@meduni_wien) 's Twitter Profile Photo

A new therapy option that targets the metastatic capacity of #melanoma cells has been discovered by a team led by Wolfgang Weninger and Shweta Tikoo from #MedUniVienna. The findings pave the way for the development of a new class of drugs. ➡ bit.ly/3R9m8sH PNASNews

Shweta Tikoo (@shwetatikoo29) 's Twitter Profile Photo

Our recent study highlighting the role of ATM kinase in melanoma invasion and metastasis is out now in PNAS PNASNews. Please check it out @ pubmed.ncbi.nlm.nih.gov/37963252/ Rohit Jain, PhD.

Centenary Institute (@centenaryinst) 's Twitter Profile Photo

Research conducted at the Centenary Institute has led to a new tool called 'Invasion-Block' that can identify drugs capable of halting the spread of cancer cells. The development could lead to better treatments for melanoma. centenary.org.au/news/new-techn… Shweta Tikoo Dr Dajiang Guo .

Research conducted at the Centenary Institute has led to a new tool called 'Invasion-Block' that can identify drugs capable of halting the spread of cancer cells. The development could lead to better treatments for melanoma. centenary.org.au/news/new-techn… <a href="/Shwetatikoo29/">Shweta Tikoo</a> <a href="/DajiangG/">Dr Dajiang Guo</a> .
Sylvia Knapp - Lab (@sylviaknapp_lab) 's Twitter Profile Photo

📢We are now accepting applications for PhD candidates.✨Shape the future of Infection Biology, as part of meduniwien.ac.at/web/en/studies… SHIELD, a PhD program at the crossroad of basic & clinical immunology & data science. Apply online by 15.04.2024. ➡️bit.ly/3l7WMhs #PhDLife

Christoph Bock Lab @ CeMM & MedUni Vienna (@bocklab) 's Twitter Profile Photo

WHAT KEEPS IMMUNE CELLS AWAKE & ATTENTIVE? It’s their neighbors – stimulation from the tissue environment. We profiled epigenomes & transcriptomes of 12 JAK-STAT mutant mice & found surprisingly strong effects at homeostasis. Paper just out in Nature Immunology: nature.com/articles/s4159…

WHAT KEEPS IMMUNE CELLS AWAKE &amp; ATTENTIVE? It’s their neighbors – stimulation from the tissue environment. We profiled epigenomes &amp; transcriptomes of 12 JAK-STAT mutant mice &amp; found surprisingly strong effects at homeostasis. Paper just out in <a href="/NatImmunol/">Nature Immunology</a>: nature.com/articles/s4159…
Philipp Starkl (@philippstarkl) 's Twitter Profile Photo

Yes, please apply if you're looking for an immunology/infectious diseases master's thesis project...it's gonna be pretty awesome 😊

Stefan Oehlers (@oehlerslab) 's Twitter Profile Photo

In case you didn't know what makes me tick at work: "those people forget that infectious diseases are still a real problem for the rest of the world... the scientific version of Robin Hood" a-star.edu.sg/News/faces-of-…

Rohit Jain, PhD. (@rohitjain_18) 's Twitter Profile Photo

Congratulations Shweta Tikoo for being awarded Researcher of the Month by the Medical University of Vienna. meduniwien.ac.at/web/forschung/… youtube.com/watch?v=1nj6tp…

Sylvia Knapp - Lab (@sylviaknapp_lab) 's Twitter Profile Photo

📢Macrophage and DC friends -> mark your calender -> the one and only #EMDS2024 will take place in Vienna, organized with IdoAmitLab, @realFlorentGinhoux and Karin de Visser. check out the exciting list of speakers 👇🏽👇🏽👇🏽and join.

📢Macrophage and DC friends -&gt; mark your calender -&gt; the one and only #EMDS2024 will take place in Vienna, organized with <a href="/IdoAmitLab/">IdoAmitLab</a>, <a href="/FGinhoux/">@realFlorentGinhoux</a> and <a href="/deVisserKarin/">Karin de Visser</a>. check out the exciting list of speakers 👇🏽👇🏽👇🏽and join.
MedUni Wien (@meduni_wien) 's Twitter Profile Photo

#Metastasis is the leading cause of death from #cancer. Despite progress, targeting the metastatic process remains a challenge. #ResearcheroftheMonth Shweta Tikoo has developed a high-throughput platform for screening drugs that inhibit #invadopodia. ➡ bit.ly/4dLQ07D

Mani Subramanian 🫀 (@mani_cvd) 's Twitter Profile Photo

📢We have an open postdoc position! Interested in developing translational approaches to modulate macrophage function for the treatment of cardiometabolic and inflammatory diseases? Apply now: jobs.ac.uk/job/DIF715 Deadline: July 2, 2024 William Harvey Research Institute London Postdoc Network

📢We have an open postdoc position!

Interested in developing translational approaches to modulate macrophage function for the treatment of cardiometabolic and inflammatory diseases?  

Apply now: jobs.ac.uk/job/DIF715
Deadline: July 2, 2024
<a href="/QMULWHRI/">William Harvey Research Institute</a> <a href="/LDN_PostdocNet/">London Postdoc Network</a>
MedUni Wien (@meduni_wien) 's Twitter Profile Photo

Research from #MedUniVienna in collaboration with Stanford University and UC San Francisco provides unprecedented insights into the dynamic remodelling of #immunecells in the metastatic niche from early #tumour development to late #metastasis. ➡ bit.ly/3WfkM1X Cancer Cell Juliane Winkler

IMBA imbavienna.bsky.social (@imba_vienna) 's Twitter Profile Photo

New research from Shane JF Cronin and Josef Penninger at the PenningerLab and Philipp Starkl at MedUni Wien shows that reducing production of the neuropathic pain mediator molecule BH4 could effectively treat chronic postoperative pain. More info: bit.ly/3T0238D

New research from <a href="/cronin_sjf/">Shane JF Cronin</a> and Josef Penninger at the <a href="/penningerlab/">PenningerLab</a> and <a href="/PhilippStarkl/">Philipp Starkl</a> at <a href="/MedUni_Wien/">MedUni Wien</a> shows that reducing production of the neuropathic pain mediator molecule BH4 could effectively treat chronic postoperative pain. More info: bit.ly/3T0238D
Rohit Jain, PhD. (@rohitjain_18) 's Twitter Profile Photo

Just out! A new study from our collaborators Shane JF Cronin, Starkl Lab Vienna, and PenningerLab at IMBA imbavienna.bsky.social and MedUni Wien. The study provides new insights into the cellular and molecular crosstalk between mast cells and nerves during postoperative pain.